145 related articles for article (PubMed ID: 11972435)
1. Postnatal glucocorticoid therapy for prevention of bronchopulmonary dysplasia: routes of administration compared.
Cole CH
Semin Neonatol; 2001 Aug; 6(4):343-50. PubMed ID: 11972435
[TBL] [Abstract][Full Text] [Related]
2. Inhaled drugs for the prevention and treatment of bronchopulmonary dysplasia.
Pantalitschka T; Poets CF
Pediatr Pulmonol; 2006 Aug; 41(8):703-8. PubMed ID: 16779858
[TBL] [Abstract][Full Text] [Related]
3. Maternal glucocorticoid therapy and reduced risk of bronchopulmonary dysplasia.
Van Marter LJ; Leviton A; Kuban KC; Pagano M; Allred EN
Pediatrics; 1990 Sep; 86(3):331-6. PubMed ID: 2201940
[TBL] [Abstract][Full Text] [Related]
4. Open-label glucocorticoids modulate dexamethasone trial results in preterm infants.
Onland W; van Kaam AH; De Jaegere AP; Offringa M
Pediatrics; 2010 Oct; 126(4):e954-64. PubMed ID: 20837588
[TBL] [Abstract][Full Text] [Related]
5. The role of inhaled steroids in the treatment of bronchopulmonary dysplasia.
Avent ML; Gal P; Ransom JL
Neonatal Netw; 1994 Apr; 13(3):63-9. PubMed ID: 7512192
[TBL] [Abstract][Full Text] [Related]
6. [Bronchopulmonary dysplasia. Retrospective analysis of various forms of treatment and development of a staged therapeutic plan].
Bauer J; Beedgen B; Böhler T; Sontheimer D; Zilow EP; Linderkamp O
Klin Padiatr; 1996; 208(2):56-60. PubMed ID: 8901183
[TBL] [Abstract][Full Text] [Related]
7. Randomized, double-blinded trial of low-dose dexamethasone: II. Functional residual capacity and pulmonary outcome in very low birth weight infants at risk for bronchopulmonary dysplasia.
McEvoy C; Bowling S; Williamson K; McGaw P; Durand M
Pediatr Pulmonol; 2004 Jul; 38(1):55-63. PubMed ID: 15170874
[TBL] [Abstract][Full Text] [Related]
8. Evidence-based neonatal drug therapy for prevention of bronchopulmonary dysplasia in very-low-birth-weight infants.
Schmidt B; Roberts R; Millar D; Kirpalani H
Neonatology; 2008; 93(4):284-7. PubMed ID: 18525211
[TBL] [Abstract][Full Text] [Related]
9. Evidence-based neonatal pharmacotherapy: postnatal corticosteroids.
Watterberg K
Clin Perinatol; 2012 Mar; 39(1):47-59. PubMed ID: 22341536
[TBL] [Abstract][Full Text] [Related]
10. Bronchopulmonary dysplasia.
Deakins KM
Respir Care; 2009 Sep; 54(9):1252-62. PubMed ID: 19712501
[TBL] [Abstract][Full Text] [Related]
11. Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter, international, randomized, controlled trial.
Doyle LW; Davis PG; Morley CJ; McPhee A; Carlin JB;
Pediatrics; 2006 Jan; 117(1):75-83. PubMed ID: 16396863
[TBL] [Abstract][Full Text] [Related]
12. Impact of perinatal corticosteroids on neuromotor development and outcome: review of the literature and new meta-analysis.
Shinwell ES; Eventov-Friedman S
Semin Fetal Neonatal Med; 2009 Jun; 14(3):164-70. PubMed ID: 19109083
[TBL] [Abstract][Full Text] [Related]
13. Postnatal betamethasone vs dexamethasone in premature infants with bronchopulmonary dysplasia: a pilot study.
DeCastro M; El-Khoury N; Parton L; Ballabh P; LaGamma EF
J Perinatol; 2009 Apr; 29(4):297-304. PubMed ID: 19052552
[TBL] [Abstract][Full Text] [Related]
14. Nebulized pentoxifylline for prevention of bronchopulmonary dysplasia in very low birth weight infants: a pilot clinical study.
Lauterbach R; Szymura-Oleksiak J; Pawlik D; Warchoł J; Lisowska-Miszczyk I; Rytlewski K
J Matern Fetal Neonatal Med; 2006 Jul; 19(7):433-8. PubMed ID: 16923699
[TBL] [Abstract][Full Text] [Related]
15. Policy statement--postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia.
Watterberg KL;
Pediatrics; 2010 Oct; 126(4):800-8. PubMed ID: 20819899
[TBL] [Abstract][Full Text] [Related]
16. Inhaled budesonide for the prevention of bronchopulmonary dysplasia.
Bassler D
J Matern Fetal Neonatal Med; 2017 Oct; 30(19):2372-2374. PubMed ID: 27756156
[TBL] [Abstract][Full Text] [Related]
17. Inhaled nitric oxide to prevent bronchopulmonary dysplasia in preterm neonates.
Mercier JC; Olivier P; Loron G; Fontaine R; Maury L; Baud O
Semin Fetal Neonatal Med; 2009 Feb; 14(1):28-34. PubMed ID: 18986855
[TBL] [Abstract][Full Text] [Related]
18. Shielding parenteral nutrition from light: does the available evidence support a randomized, controlled trial?
Sherlock R; Chessex P
Pediatrics; 2009 Jun; 123(6):1529-33. PubMed ID: 19482764
[TBL] [Abstract][Full Text] [Related]
19. Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants (the SToP-BPD study); a multicenter randomized placebo controlled trial.
Onland W; Offringa M; Cools F; De Jaegere AP; Rademaker K; Blom H; Cavatorta E; Debeer A; Dijk PH; van Heijst AF; Kramer BW; Kroon AA; Mohns T; van Straaten HL; te Pas AB; Theyskens C; van Weissenbruch MM; van Kaam AH
BMC Pediatr; 2011 Nov; 11():102. PubMed ID: 22070744
[TBL] [Abstract][Full Text] [Related]
20. Effects of higher versus lower dexamethasone doses on pulmonary and neurodevelopmental sequelae in preterm infants at risk for chronic lung disease: a meta-analysis.
Onland W; De Jaegere AP; Offringa M; van Kaam AH
Pediatrics; 2008 Jul; 122(1):92-101. PubMed ID: 18595991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
